Activity in this selectionOct 4, 2026 · Biotech · Jul 7, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- —
1 roles undisclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $120M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionAusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B
Role not disclosed